The Levofloxacin Injection, cataloged under National Stock Number 6505-01-666-3944, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: CS.
| Parameter | Value |
|---|---|
| NSN | 6505-01-666-3944 |
| Primary Part Number | NDC25021-0132-83 |
| Item Name | Levofloxacin Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | CS |
| Part Number | Manufacturer |
|---|---|
| NDC25021-0132-83 PRIMARY | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc (USA) |
| 245597 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| NDC00143-9720-24 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC00143-9720-24 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM173706 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1482320 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-666-3944 is a Levofloxacin Injection, manufactured by Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-666-3944 has 4 manufacturer part numbers on file: NDC25021-0132-83 (Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc), 245597 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office), NDC00143-9720-24 (Hikma Pharmaceuticals Usa Inc.), NDC00143-9720-24 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC25021-0132-83: Special Features: LEVOFLOXACIN, 750 MG/150 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK, 150ML; CASE OF 24; GENERIC NAME: LEVOFLOXACIN IN 5% DEXTROSE INJECTION; BRAND NAME LEVAQUIN; THERAPEUTIC CATEGORY: ANTIBACTERIAL; DESCRIPTION: CLEAR, GREEN TO YELLOW SOLUTION; FORM: INJECTION ; CLOSURE: 5.2 MM; RATING: AP; STORE AT OR BELOW 25 C (77 F); HOWEVER, BRIEF EXPOSURE UP TO 40 C (104 F) DOES NOT ADVERSELY AFFECT THE PRODUCT. AVOID EXCESSIVE HEAT AND PROTECT FROM FREEZING AND LIGHT. MM; Part Name Assigned by Controlling Agency: LEVOFLOXACIN 750 MG/150 ML-D5W 150ML, 24S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.